Rigel Pharmaceuticals 8K Entry into a Material Definitive Agreement | RIGL 2 Feb 05

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

Name and Title	Salary
James M. Gower	$	425,000
Chief Executive Officer, Chairman of the Board and Director
Donald G. Payan	$	370,000
Executive Vice President and Scientific Officer and Director
Elliot B. Grossbard	$	340,200
Senior Vice President, Medical Development
Raul R. Rodriguez	$	330,000
Executive Vice President, Chief Operating Officer
Dolly A. Vance	$	315,000
General Counsel and Vice President of Intellectual Property

Rigel Pharmaceuticals (RIGL) 8-KEntry into a Material Definitive Agreement